A&D Pharma intends to give up London Stock Exchange listing next year

Newsroom 20/12/2010 | 16:23

A&D Pharma intends to give up the listing from the London Stock Exchange. A decision in this sense will be made at the end of January, according to Mediafax newswire.

The last day of transaction with the company’s shares will be February 28, 2011. A&D Pharma has been listed at the London Stock Exchange since 2006. The company posted EUR 482.2 million in the first nine months of the year, which represented 32 percent growth on the similar period of 2009.

The main shareholder in A&D Pharma is Sograno, with a 59 percent stake, a company registered in The Netherlands. Sograno is owned by Michel Eid, Ludovic Robert, Roger Akoury and Walid Abboud. A stake of 34 percent is transactioned on the capital market and the remaining 7 percent belongs to former CEOs of the company.

Otilia Haraga


BR Magazine | Latest Issue

Download PDF: Business Review Magazine November 2023 Issue

The November 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Mastercard On a Mission to Build an Inclusive Digital Economy”. To
Newsroom | 27/11/2023 | 17:41
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue